News

Onlymyhealth3d
What Happens When Blood Doesn’t Clot? Know The Science Behind Factor Deficiencies In Hemophilia
If blood clotting is affected for a longer period of time it can cost your life! Read this article to understand more about ...
Yahoo Finance3d
Children's Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients
X-linked disorder resulting from a deficiency in coagulation factor IX (FIX) activity. The findings, which support the potential of this gene therapy as a safe and effective long-term solution for ...
ABP News on MSN3d
World Haemophilia Day 2025 — Understanding The Rare Bleeding Disorder
By: Dr. Vijay Ramanan Haemophilia B constitutes a severe rare genetic bleeding condition which interferes strongly with blood ...
Managed Healthcare Executive9d
FDA Approves First Prophylactic Therapy for Hemophilia A or B With or Without Inhibitors
Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...
Pharmaceutical Technology on MSN9d
NMPA approves BBM and Takeda China’s haemophilia B therapy
Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...
Managing Haemophilia: Joint Pain, Mental Strain, and Medical Strategy
On World Haemophilia Day, it’s essential to spread awareness about this condition—not just to highlight the challenges ...
World Haemophilia Day 2025: Know causes, symptoms and preventive measures of this genetic blood disorder
Learn about haemophilia, a genetic blood disorder, on World Haemophilia Day 2025. Know its causes, symptoms, and preventive ...
The New England Journal of Medicine4d
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study
Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX ...